(Q38254356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

The potential to target CCL5/CCR5 in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

Marco A. Velasco-Velazquez

20 February 2020

author

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Wendy Xolalpa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3

Richard G Pestell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

26 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1265-1275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256399%20AND%20SRC:MED&resulttype=core&format=json

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Breast cancer control: signs of progress, but more work required

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Chemokines and chemokine receptors: positioning cells for host defense and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Targeting CCL5 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

CCR5 antagonist blocks metastasis of basal breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

RANTES: a versatile and controversial chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

The unexpected pleiotropic activities of RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Expression of CCL5 (RANTES) and CCR5 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Association of chemotactic factor receptor 5 gene with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Chemokine decoy receptor d6 plays a negative role in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Imagable 4T1 model for the study of late stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Changes in chemokine receptor expression of regulatory T cells after ex vivo culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Tumor microenvironment and myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Myeloid-derived suppressor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Tumor-derived CCL5 does not contribute to breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Chemokine control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

No Association between Common Chemokine and Chemokine Receptor Gene Variants and Prostate Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

17β-estradiol inhibits mesenchymal stem cells-induced human AGS gastric cancer cell mobility via suppression of CCL5- Src/Cas/Paxillin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.949238